Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
暂无分享，去创建一个
David A. Smith | A. Tan | C. Fabian | J. O’Shaughnessy | E. Tan-chiu | J. Blum | L. Vahdat | E. Chuang | R. Rivera | D. Shuster | S. Ashworth | F. Fang | K. Chandrawansa | Patricia E. Cole | Jonathan Wright | B. Pruitt | John Smith | N. Meneses | N. Dacosta